🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Barrett Esophagus

Lucid Registry Study NCT05965999n/a1 site📍 Lake Forest Lucid Diagnostics, Inc. · Tests: EsoCheck®, EsoGuard® Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux NCT06746623NA1 site📍 Cleveland Louis Stokes VA Medical Center · Tests: Enrolled participants will complete Esocheck/Esoguard and diagnostic upper endoscopy. Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms NCT06687603NA5 sites📍 Aurora📍 Baltimore📍 Chapel Hill Case Comprehensive Cancer Center · Tests: EsoCheck, EsoGuard Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype NCT06532734n/a3 sites📍 Denver📍 Denver📍 Denver Denver Health and Hospital Authority · Tests: EsoGuard TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) NCT02634645n/a4 sites📍 Los Angeles📍 Tampa📍 Chicago University of Colorado, Denver · Tests: Endoscopic eradication therapies (EET), Esophagectomy, Chemotherapy, Radiation Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia NCT05753748NA30 sites📍 Birmingham📍 Scottsdale📍 Los Angeles University of Colorado, Denver · Tests: Endoscopic Eradication Therapy Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System NCT02947971NA1 site📍 Boston Massachusetts General Hospital · Tests: Experimental OFDI Imaging Longitudinal Oral Microbiome Sampling for BE NCT05133102n/a2 sites📍 Ann Arbor📍 New York Columbia University · Tests: Sample collection Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples NCT06803927n/a1 site📍 Cordova Cyted Health Inc · Tests: Barrett's Esophagus Test (LDT) Barrett's Esophagus Related Neoplasia (BERN) Project NCT00590239n/a1 site📍 Kansas City Midwest Biomedical Research InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples Impact of RFA on Esophageal Distensibility and Mucosal Impedance NCT07126535n/a1 site📍 Rochester Mayo Clinic · Tests: Radiofrequency ablation alone EMR Versus ESD for Barrett's Neoplasia NCT05276791NA6 sites📍 Amsterdam📍 Eindhoven📍 Groningen St. Antonius Hospital · Tests: EMR, ESD Ultralong-segment Barrett's Esophagus: Towards a Capsule-sponge Surveillance Strategy NCT06720636NA1 site📍 Rotterdam Erasmus Medical Center · Tests: EndoSign A Multicenter Prospective Cohort Study Comparing Random Biopsies Versus Wide-Area Transepithelial Brush-Sampling (WATS) for Surveillance of Barrett's Esophagus, the WATS-EURO2 Study NCT05642338n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: WATS3D Digma System First in Human (FIH) Study NCT07331857NA1 site📍 Brno Digma Medical Ltd. · Tests: Endoscopic Gastrointestinal Ablation Device (EGAD) Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry NCT00574327n/a1 site📍 Kansas City Midwest Biomedical Research Preoperative Predictors of Symptom Improvement After Laparoscopic Fundoplication NCT07809620n/a1 site📍 Minya Minia University · Tests: Laparoscopic Nissen fundoplication, Laparoscopic Toupet fundoplication EsophaCap for the Detection of Early Esophageal Carcinoma NCT04214119n/a2 sites📍 Baltimore📍 Baltimore Johns Hopkins University Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples NCT06071845NA5 sites📍 Scottsdale📍 Jacksonville📍 Chicago Mayo Clinic · Tests: Cytosponge Procedure, Endoscopic Assessment The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE NCT05818072NA1 site📍 Kaohsiung City E-DA Hospital · Tests: One biopsy, Three biopsy, Seattle protocol, Endoscopy Navicam for Detection of Barrett's Esophagus NCT06748911NA1 site📍 Jacksonville Mayo Clinic · Tests: NaviCam Detachable String Capsule Endoscopic Submucosal Dissection (ESD) NCT05468008n/a1 site📍 Orlando AdventHealth · Tests: Endoscopic Submucosal Dissection A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer NCT06523374NA9 sites📍 Edegem📍 Wilrijk📍 Ghent University Hospital, Antwerp · Tests: Endoscopic brush cytology Molecular Assessment for Gastro-Esophageal Cancer NCT06346054NA1 site📍 Leuven KU Leuven · Tests: Breath analysis, Blood analysis Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus NCT03830801NA1 site📍 Boston Massachusetts General Hospital · Tests: IVLCM tethered capsule Australian Barrett's Cohort With Dysplasia and Early Cancer Study NCT02198976n/a1 site📍 Westmead Professor Michael Bourke Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance NCT05530343NA14 sites📍 Gilbert📍 Los Angeles📍 Oakland University of Colorado, Denver · Tests: Seattle protocol, WATS3D brushings Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests NCT06693622n/a1 site📍 Aurora University of Colorado, Denver · Tests: Patient survey "Less-is-more in Barrett-surveillance" Care Evaluation of Barrett's Patients With Low-Risk in Whom Endoscopic Surveillance is Stopped. The BLISS Project. NCT06803147n/a1 site📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: Discontinued endoscopic surveillance
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy